Evidence map›Paper›PMID 33708545›Full record

ArticleGland surgery2021

Is primary total pancreatectomy in patients with high-risk pancreatic remnant justified and preferable to pancreaticoduodenectomy? -a matched-pairs analysis of 200 patients.

Andreas Minh Luu, Bella Olchanetski, Torsten Herzog, Andrea Tannapfel, Waldemar Uhl, Orlin Belyaev

Open access · diamondAbstract read
In one paragraph

Article in Gland surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Long-term effects of totalAnnals of translational medicine · 2022
    Article
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Andreas Minh LuuDepartment of Surgery, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany.
Bella OlchanetskiDepartment of Surgery, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany.
Torsten HerzogDepartment of Surgery, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany.
Andrea TannapfelInstitute of Pathology, Ruhr University Bochum, Bochum, Germany.
Waldemar UhlDepartment of Surgery, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany.
Orlin BelyaevDepartment of Surgery, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany.
Ruhr University Bochum · DESt. Josef-Hospital · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTotal pancreatectomy (TP) eliminates the risk of postoperative pancreatic fistula (POPF) and its associated secondary complications. Hence, it may theoretically offer advantages over pancreaticoduodenectomy (PD) regarding early postoperative outcome of patients with high-risk pancreatic remnant.

methodsNinety-day mortality and morbidity of 100 TP

resultsPreoperatively, the TP-group was characterized by poorer general condition, more comorbidities and more pronounced obesity than the PD-group. Postoperatively, overall morbidity was lower after TP (63%

conclusionsTP may reduce severe POPF-associated complications and prevent mortality related to emergency completion pancreatectomy in some elderly, obese and polymorbid patients with high-risk pancreatic remnant. Careful individual selection by an experienced pancreatic surgeon is mandatory.

Indexed as

morbidityoutcomePancreatectomypancreatic fistulapancreaticoduodenectomy

Identifiers

PMID33708545
PMCPMC7944076
OpenAlexW3113098622

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.